
    
      In detail, the following questions will be answered:

        1. Are there different phenotypes with respect to insulin secretion, insulin sensitivity,
           micro- and macrovascular status and diabetic neuropathy at time of diagnosis?

        2. Which factors modify the progression of the disease (Nutrition, subclinical
           inflammation, energy metabolism and physical activity)?

        3. Can we identify subgroups at baseline with different progression of the disease?
           Patients are thoroughly examined at baseline and after 2, 5, and 10 years with annual
           telephone contacts in between.
    
  